Clinical Pathology Laboratories Investor Relations Manager Salary | Comparably
Clinical Pathology Laboratories, Inc. (CPL) has served the medical community for over sixty years. Over 1850 employees work at our 100,000 read more
EMPLOYEE
PARTICIPANTS
37
TOTAL
RATINGS
268

Clinical Pathology Laboratories Investor Relations Manager Salary

The average Clinical Pathology Laboratories Investor Relations Manager earns an estimated $90,029 annually. Clinical Pathology Laboratories' Investor Relations Manager compensation is $2,725 more than the US average for a Investor Relations Manager.

The Communications Department at Clinical Pathology Laboratories earns $4,005 more on average than the Business Development Department.

Last updated a year ago.

$51k
$64k
$75k
$85k
$114k
$175k
$90,029
Average Compensation
$90,029
avg. base

Investor Relations Manager Salaries at Clinical Pathology Laboratories

Investor Relations Managers earn $10,028 more than Editors.

Editor
$80k*
* estimated salary

Compensation at Clinical Pathology Laboratories by Department

The Communications Department averages $4,005 more than the Business Development Department, and $2,504 less than the Finance Department

Finance
$79,924 Avg. total comp.
+$3k
Communications
$77,420 Avg. total comp.
Business Development
$73,415 Avg. total comp.
-$4k

Investor Relations Manager Compensation by Gender (All Companies)

The average female Investor Relations Manager at companies similar size to Clinical Pathology Laboratories reported making $113,250, while the average male Investor Relations Manager at similar sized companies reported making $68,100.

Investor Relations Manager Compensation by Ethnicity (All Companies)

The average Caucasian Investor Relations Manager at companies similar size to Clinical Pathology Laboratories reported making $102,750, while the average African American/Black Investor Relations Manager at similar sized companies reported making $76,200.

How Investor Relations Managers at Clinical Pathology Laboratories Rate Their Compensation

The majority of Investor Relations Managers at Clinical Pathology Laboratories believe they're not compensated fairly. The vast majority (73%) of Investor Relations Managers at Clinical Pathology Laboratories are satisfied with their benefits. See more compensation ratings at Clinical Pathology Laboratories

×
Rate your company